What are the major opportunities in the Shingrix (Zostavax) market? What are the strategies for the Shingrix (Zostavax) market?

For detailed insights on the major opportunities and strategies in the Shingrix (Zostavax) market, Read More

How does the Shingrix (Zostavax) market relate to the overall economy and other similar markets?

For detailed insights on Shingrix (Zostavax)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Shingrix (Zostavax) market growth? SWOT analysis of the Shingrix (Zostavax) market.

For detailed insights on the key dynamics influencing the Shingrix (Zostavax) market growth and SWOT analysis of the Shingrix (Zostavax) industry, Read More

Global Shingrix Zostavax Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Shingrix (Zostavax) Global Market Report 2025

Name: Shingrix (Zostavax) Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Formulation (Recombinant Vaccine (Shingrix), Live Attenuated Vaccine (Zostavax)), By Indication (Shingles Prevention, Post-Herpetic Neuralgia), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Shingrix (Zostavax) Market?

Shingrix (Zostavax) refers to a vaccine designed to prevent shingles (herpes zoster), a painful rash caused by the reactivation of the varicella-zoster virus. It is used for immunizing adults, particularly those aged 50 and older, to reduce the risk of developing shingles and its complications.

The main types of formulation in shingrix (zostavax) are recombinant vaccines (shingrix) and live-attenuated vaccines (zostavax). Recombinant vaccine (shingrix) refers to a non-live vaccine developed using recombinant DNA technology to prevent shingles, which stimulates the immune system by introducing a protein from the varicella-zoster virus, providing strong protection against the disease. The indications include shingles prevention and post-herpetic neuralgia with distribution channels such as Hospital Pharmacy and retail pharmacy.

Shingrix (Zostavax) Market Size and growth rate 2025 to 2029: Graph

What Is The Shingrix (Zostavax) Market Size 2025 And Growth Rate?

The shingrix (zostavax) market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased vaccine adoption, a rise in the need for educational campaigns, an increased focus on preventive healthcare, a rise in patient education and advocacy efforts, and a rise in insurance coverage for immunization.

What Is The Shingrix (Zostavax) Market Growth Forecast?

The shingrix (zostavax) market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising geriatric population, increasing incidence of herpes zoster, rising incidence of chickenpox, increasing disease prevalence, and growing awareness about shingles and its complications. Major trends in the forecast period include innovative recombinant vaccines, advancements in vaccine development, a shift towards disease prevention over treatment, AI-powered vaccine research and development, and advanced biomarker identification for shingles susceptibility.

Book your 30 minutes free consultation with our research experts

How Is The Shingrix (Zostavax) Market Segmented?

The shingrix (zostavax) market covered in this report is segmented –

1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax)

2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy

What Is Driving The Shingrix (Zostavax) Market? Growing Adoption Of Vaccination Drives The Market Growth

The growing adoption of vaccination is expected to propel the growth of the shingrix (zostavax) market going forward. Vaccination refers to the process of administering a vaccine to stimulate the body's immune system to recognize and fight specific pathogens. The growing adoption of vaccination is attributed to increased awareness of its effectiveness in preventing diseases, reducing disease burden, and the development of safe and accessible vaccines. Public health campaigns, improved healthcare infrastructure, and global vaccination initiatives also contribute to its widespread acceptance. Shingrix (Zostavax) is beneficial for vaccination by providing effective protection against shingles and its complications. It is particularly beneficial for adults over 50, significantly reducing the risk of shingles recurrence and post-herpetic neuralgia. For instance, in May 2024, according to a study published by the Journal of the American Medical Association (JAMA), a US-based peer-reviewed medical journal, the shingles vaccinations covered by Medicare Part D increased by 46% in the year following the IRA policy's implementation in January 2023. Moreover, in 2022, according to the Australian Government Department of Health and Aged Care, an Australia-based government agency, the Australian government ensured that COVID-19 vaccines were freely available to all Australians. By mid-2022, over 34 million primary vaccinations and boosters had been administered, with general practices playing a significant role in the rollout, especially in rural areas. Therefore, the growing adoption of vaccination is driving the growth of the shingrix (zostavax) market.

Who Are The Major Players In The Global Shingrix (Zostavax) Market?

Major companies operating in the shingrix (zostavax) market are GSK plc

What Are The Key Trends Of The Global Shingrix (Zostavax) Market? Innovative Non-Live, Recombinant Subunit Vaccines Enhance Market Growth

A key trend in the shingrix (zostavax) market is developing innovative products, such as non-live, recombinant subunit adjuvanted vaccines, to enhance vaccine efficacy and address age-related immune decline in vulnerable populations. A non-live, recombinant subunit adjuvanted vaccine contains specific protein components of a pathogen combined with an adjuvant to enhance the immune response. For instance, in September 2024, GSK plc, a UK-based biopharma company, launched the shingles vaccine Shingrix. Recombinant Zoster Vaccine (RZV) is a non-live vaccine offering up to 97% efficacy in preventing shingles and post-herpetic neuralgia. It is designed for adults aged 50+ and immunocompromised individuals aged 18+, administered intramuscularly in two doses. In the ZOE-50 study, RZV showed up to 97% efficacy in adults 50+ over three years, with recent data indicating over 80% efficacy lasting 6–10 years post-vaccination.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Shingrix (Zostavax) Market? GSK Partners With Chongqing Zhifei To Expand Shingrix's Reach In China

In October 2023, Chongqing Zhifei, a China-based biotechnology company that specializes in the development, manufacturing, and distribution of vaccines, partnered with GSK plc. With this partnership, GSK plc aims to expand the market reach of its top-selling shingles vaccine, shingrix, in China, the world’s second-largest pharmaceutical market, by spending. GSK plc, a UK-based pharmaceutical industry company that manufactures shingrix (zoster vaccine recombinant).

Regional Analysis For The Global Shingrix (Zostavax) Market

North America was the largest region in the shingrix (zostavax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingrix (zostavax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the shingrix (zostavax) market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Shingrix (Zostavax) Market?

The shingrix (zostavax) market consists of sales of single-dose vials and pre-filled syringes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Shingrix (Zostavax) Industry?

The shingrix (zostavax) market research report is one of a series of new reports from The Business Research Company that provides shingrix (zostavax) market statistics, including shingrix (zostavax) industry global market size, regional shares, competitors with a shingrix (zostavax) market share, detailed shingrix (zostavax) market segments, market trends and opportunities, and any further data you may need to thrive in the shingrix (zostavax) industry. This shingrix (zostavax) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Shingrix Zostavax Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The shingrix (zostavax) market covered in this report is segmented – 1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax) 2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	GSK plc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Shingrix (Zostavax) Market Characteristics

3. Shingrix (Zostavax) Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Shingrix (Zostavax) Market Trends And Strategies

5. Shingrix (Zostavax) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Shingrix (Zostavax) Growth Analysis And Strategic Analysis Framework

6.1. Global Shingrix (Zostavax) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Shingrix (Zostavax) Market Growth Rate Analysis

6.4. Global Shingrix (Zostavax) Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Shingrix (Zostavax) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Shingrix (Zostavax) Total Addressable Market (TAM)

7. Global Shingrix (Zostavax) Pricing Analysis & Forecasts

8. Shingrix (Zostavax) Market Segmentation

8.1. Global Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Recombinant Vaccine (Shingrix)

Live Attenuated Vaccine (Zostavax)

8.2. Global Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Shingles Prevention

Post-Herpetic Neuralgia

8.3. Global Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacy

Retail Pharmacy

9. Global Shingrix (Zostavax) Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Shingrix (Zostavax) Market Regional And Country Analysis

10.1. Global Shingrix (Zostavax) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Shingrix (Zostavax) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Shingrix (Zostavax) Market

11.1. Asia-Pacific Shingrix (Zostavax) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Shingrix (Zostavax) Market

12.1. China Shingrix (Zostavax) Market Overview

12.2. China Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Shingrix (Zostavax) Market

13.1. India Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Shingrix (Zostavax) Market

14.1. Japan Shingrix (Zostavax) Market Overview

14.2. Japan Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Shingrix (Zostavax) Market

15.1. Australia Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Shingrix (Zostavax) Market

16.1. South Korea Shingrix (Zostavax) Market Overview

16.2. South Korea Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Shingrix (Zostavax) Market

17.1. Western Europe Shingrix (Zostavax) Market Overview

17.2. Western Europe Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Shingrix (Zostavax) Market

18.1. UK Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Shingrix (Zostavax) Market

19.1. Germany Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Shingrix (Zostavax) Market

20.1. France Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Shingrix (Zostavax) Market

21.1. Eastern Europe Shingrix (Zostavax) Market Overview

21.2. Eastern Europe Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Shingrix (Zostavax) Market

22.1. North America Shingrix (Zostavax) Market Overview

22.2. North America Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Shingrix (Zostavax) Market

23.1. USA Shingrix (Zostavax) Market Overview

23.2. USA Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Shingrix (Zostavax) Market

24.1. Canada Shingrix (Zostavax) Market Overview

24.2. Canada Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Shingrix (Zostavax) Market

25.1. South America Shingrix (Zostavax) Market Overview

25.2. South America Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Shingrix (Zostavax) Market

26.1. Middle East Shingrix (Zostavax) Market Overview

26.2. Middle East Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Shingrix (Zostavax) Market

27.1. Africa Shingrix (Zostavax) Market Overview

27.2. Africa Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Shingrix (Zostavax) Market Competitive Landscape And Company Profiles

28.1. Shingrix (Zostavax) Market Competitive Landscape

28.2. Shingrix (Zostavax) Market Company Profiles

28.2.1. GSK plc Overview, Products and Services, Strategy and Financial Analysis

29. Global Shingrix (Zostavax) Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Shingrix (Zostavax) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Shingrix (Zostavax) Market

32. Recent Developments In The Shingrix (Zostavax) Market

33. Shingrix (Zostavax) Market High Potential Countries, Segments and Strategies

33.1 Shingrix (Zostavax) Market In 2029 - Countries Offering Most New Opportunities

33.2 Shingrix (Zostavax) Market In 2029 - Segments Offering Most New Opportunities

33.3 Shingrix (Zostavax) Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Shingrix (Zostavax) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Shingrix (Zostavax) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: GSK plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Shingrix (Zostavax) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Shingrix (Zostavax) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Shingrix (Zostavax) Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Shingrix (Zostavax) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Shingrix (Zostavax) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: GSK plc Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Immunoglobulin E (IgE) Allergy Blood Tests Global Market Report 2025 – By Product Type (Assays And Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Testing Kits, Fluorescent Enzyme Immunoassays (FEIA) Testing Kits, Chemil...

Immunomodulator Global Market Report 2025 – By Product Type (Immunosuppressants, Immunostimulants, Other Product Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Ch...

Nontuberculous Mycobacterial Infection Global Market Report 2025 – By Drug Class (Macrolides, Rifampin, Aminoglycoside, Other Drug Classes), By Route Of Administration (Oral, Parenteral, Other Routes), By Distribution Ch...

High Level Disinfection Services Global Market Report 2025 – By Services( In House, Outsource), By Compound( Formaldehyde, Glutaraldehyde, Ortho-Phthalaldehyde, Hydrogen Peroxide, Peracetic Acid, Other Components), By En...

Pseudomonas Aeruginosa Infection Treatment Global Market Report 2025 – By Medication (Monotherapy, Combination Therapy ), By Drug Class (Aminoglycoside, Cephalosporin, Carbapenem, Monobactum, Other Drug Classes), By Rout...

Infection Control Global Market Report 2025 – By Type (Disinfectors, Sterilization, Equipment, Consumables And Accessories, Services), By Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), By A...

Urinary Tract Infection Treatment Global Market Report 2025 – By Drug Class (Penicillin And Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides, Azoles And Amphotericin B, Tetracycline, Nit...

Frequently Asked Questions

What is the definition of the Shingrix (Zostavax) market?

How will the Shingrix (Zostavax) market drivers and restraints affect the market dynamics? What forces will shape the Shingrix (Zostavax) industry going forward?

The Shingrix (Zostavax) market major growth driver - Growing Adoption Of Vaccination Drives The Market Growth. For further insights on the Shingrix (Zostavax) market, request a sample here

What is the forecast market size or the forecast market value of the Shingrix (Zostavax) market?

The Shingrix (Zostavax) market size has grown strongly in recent years. The shingrix (zostavax) market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased vaccine adoption, a rise in the need for educational campaigns, an increased focus on preventive healthcare, a rise in patient education and advocacy efforts, and a rise in insurance coverage for immunization. The shingrix (zostavax) market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising geriatric population, increasing incidence of herpes zoster, rising incidence of chickenpox, increasing disease prevalence, and growing awareness about shingles and its complications. Major trends in the forecast period include innovative recombinant vaccines, advancements in vaccine development, a shift towards disease prevention over treatment, AI-powered vaccine research and development, and advanced biomarker identification for shingles susceptibility. For further insights on the Shingrix (Zostavax) market, request a sample here

How is the Shingrix (Zostavax) market segmented?

The shingrix (zostavax) market covered in this report is segmented –
1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax)
2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy For further insights on the Shingrix (Zostavax) market, request a sample here

Which region has the largest share of the Shingrix (Zostavax) market? What are the other regions covered in the report?

Who are the major players in the Shingrix (Zostavax) market?

Major companies operating in the shingrix (zostavax) market are GSK plc . For further insights on the Shingrix (Zostavax) market, request a sample here.

What are the key trends in the Shingrix (Zostavax) market?

Major trends in the Shingrix (Zostavax) market include Innovative Non-Live, Recombinant Subunit Vaccines Enhance Market Growth. For further insights on the Shingrix (Zostavax) market, request a sample here.